Influence of hepatitis C virus coinfection on CD4+ T cells of HIV-infected patients receiving HAART

AIDS

Volumn 28, Issue 16, 2014, Pages 2381-2388

  Shmagel, Konstantin V ^a   Saidakova, Evgeniya V ^a   Korolevskaya, Larisa B ^a   Shmagel, Nadezhda G ^b   Chereshnev, Valeriy A ^c   Anthony, Donald D ^d   Lederman, Michael M ^d  

^a INSTITUTE OF ECOLOGY AND GENETICS OF MICROORGANISMS   (Russian Federation)

^b Perm Regional Center for Protection Against AIDS and Infectious Diseases   (Russian Federation)

^c INSTITUTE OF METALLURGY   (Russian Federation)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Antigens; Antiretroviral therapy; CD31; CD4+ lymphocyte count; Hepatitis C; Highly active; HIV infections; T lymphocyte subsets; Treatment failure

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ASPARTATE AMINOTRANSFERASE; LIVER ENZYME; MONOCLONAL ANTIBODY; ANTIRETROVIRUS AGENT;

ADULT; APOPTOSIS; ARTICLE; BLOOD LEVEL; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PHENOTYPE; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; CD4 LYMPHOCYTE COUNT; CHRONIC HEPATITIS C; COMPLICATION; HIV INFECTIONS; IMMUNOLOGY; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COINFECTION; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; MALE; T-LYMPHOCYTE SUBSETS;

EID: 84916642076     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000418     Document Type: Article

References (31)

1. Fierer DS, Uriel AJ, Carriero DC, Klepper A, Dieterich DT, Mullen MP, et al. Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV infected men: a prospective cohort study. J Infect Dis 2008;198:683-686.
2. Mohsen AH, Easterbrook P, Taylor CB, Norris S. Hepatitis C and HIV 1 coinfection. Gut 2002;51:601-608.
3. Al-Harthi L, Voris J, Du W, Wright D, Nowicki M, Frederick T, et al. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV coinfected women: role of HCV on expression of primed/memory T cells. J Infect Dis 2006;193:1202-1210.
4. Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV 1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000;356:1800-1805.
5. Kaufmann GR, Perrin L, Pantaleo G, Opravil M, Furrer H, Telenti A, et al. CD4 T-lymphocyte recovery in individuals with advanced HIV 1 infection receiving potent antiretroviral therapy for 4 years. Arch Intern Med 2003;163:2187-2195.
6. Miller MF, Haley C, Koziel MJ, Rowley CF. Impact of hepatitis C virus on immune restoration in HIV infected patients who start highly active antiretroviral therapy: a meta-analysis. Clin Infect Dis 2005;41:713-720.
7. Potter M, Odueyungbo A, Yang H, Saeed S, Klein MB. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV HCV coinfection before and after antiretroviral therapy. AIDS 2010;24:1857-1865.
8. Sullivan PS, Hanson DL, Teshale EH, Wotring LL, Brooks JT. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy. AIDS 2006;20:1171-1179.
9. Lederman MM, Calabrese L, Funderburg NT, Clagett B, Medvik K, Bonilla H, et al. Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. J Infect Dis 2011;204:1217-1226.
10. Kozlov AP, Shaboltas AV, Toussova OV, Verevochkin SV, Masse BR, Perdue T, et al. HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, Russia. AIDS 2006;20:901-906.
11. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526.
12. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999;179:859-870.
13. Fink PJ. The biology of recent thymic emigrants. Annu Rev Immunol 2013;31:31-50.
14. Méndez-Lagares G, García-Pergañeda A, del Mar del Pozo-Balado M, Genebat M, Ruiz-Mateos E, García García M, et al. Differential alterations of the CD4 and CD8 T cell subsets in HIV-infected patients on highly active antiretroviral therapy with low CD4 T cell restoration. J Antimicrob Chemother 2012;67:1228-1237.
15. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, Lampiris H, Deeks SG. T cell activation is associated with lower CD4R T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003;187:1534-1543.
16. Anthony KB, Yoder C, Metcalf JA, DerSimonian R, Orenstein JM, Stevens RA, et al. Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover. J Acquir Immune Defic Syndr 2003;33:125-133.
17. Bazdar DA, Kalinowska M, Sieg SF. Interleukin-7 receptor signaling is deficient in CD4+ T cells from HIV-infected persons and is inversely associated with aging. J Infect Dis 2009;199:1019-1028.
18. Hunt PW, Martin JN, Sinclair E, Epling L, Teague J, Jacobson MA, et al. Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J Infect Dis 2011;203:1474-1483.
19. Valdez H, Anthony D, Farukhi F, Patki A, Salkowitz J, Heeger P, et al. Immune responses to hepatitis C and nonhepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients. AIDS 2000;4:2239-2246.
20. Massanella M, Negredo E, Pérez-Alvarez N, Puig J, Ruiz-Hernández R, Bofill M, et al. CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART. AIDS 2010;24:959-968.
21. Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med 1999;5:83-89.
22. Vispo E, Barreiro P, Plaza Z, Fernández-Montero JV, Labarga P, de Mendoza C, et al. Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapy. AIDS 2014;28:1473-1478.
23. Endo T, Fujimoto K, Nishio M, Yamamoto S, Obara M, Sato N, Koike T. Case report: clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus. J Med Virol 2009;81:979-982.
24. Falconer K, Gonzalez VD, Reichard O, Sandberg JK, Alaeus A. Spontaneous HCV clearance in HCV/HIV-1 coinfection associated with normalized CD4 counts, low level of chronic immune activation and high level of T cell function. J Clin Virol 2008;41:160-163.
25. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998;396:690-695.
26. Benveniste O, Flahault A, Rollot F, Elbim C, Estaquier J, Pédron B, et al. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads. J Infect Dis 2005;191:1670-1679.
27. Yonkers NL, Sieg S, Rodriguez B, Anthony DD. Reduced naive CD4 T cell numbers and impaired induction of CD27 in response to T cell receptor stimulation reflect a state of immune activation in chronic hepatitis C virus infection. J Infect Dis 2011;203:635-645.
28. Cianci R, Pinti M, Nasi M, Starnino S, Cammarota G, Miele L, et al. Impairment of recent thymic emigrants in HCV infection. Int J Immunopathol Pharmacol 2005;18:723-728.
29. Hartling HJ, Gaardbo JC, Ronit A, Salem M, Laye M, Clausen MR, et al. Impaired thymic output in patients with chronic hepatitis C virus infection. Scand J Immunol 2013;78:378-386.
30. Roe B, Coughlan S, Dean J, Lambert JS, Keating S, Norris S, et al. Phenotypic characterization of lymphocytes in HCV/HIV coinfected patients. Viral Immunol 2009;22:39-48.
31. Lario M, Muñoz L, Ubeda M, Borrero MJ, Martínez J, Monserrat J, et al. Defective thymopoiesis and poor peripheral homeostatic replenishment of T-helper cells cause T-cell lymphopenia in cirrhosis. J Hepatol 2013;59:723-730.